1. Home
  2. Browse Decisions
  3. F.3d
  4. 981 F.3d
  5. 981 F.3d 1030 (2020)
 

VECTURA LTD. v. GLAXOSMITHKLINE LLC

2020-1054.

981 F.3d 1030 (2020)

VECTURA LIMITED, Plaintiff-Appellee v. GLAXOSMITHKLINE LLC, Glaxo Group Limited, Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: November 19, 2020.

Attorney(s) appearing for the Case

Christopher P. Borello , Venable LLP, New York, NY, argued for plaintiff-appellee. Also represented by Damien N. Dombrowski , Michael S. Scerbo , Joshua Daniel Calabro , Dominick A. Conde .

William F. Lee , Wilmer Cutler Pickering Hale and Dorr LLP, Boston, MA, argued for defendants-appellants. Also represented by Christopher R. Noyes , New York, NY; Thomas Saunders , David P. Yin , Washington, DC.

Before Prost, Chief Judge, Bryson and Wallach, Circuit Judges.

Following trial, a jury in the United States District Court for the District of Delaware found that defendants GlaxoSmithKline LLC and Glaxo Group Limited (collectively, "GSK") infringed U.S. Patent No. 8,303,991 ("the '991 patent"), owned by plaintiff Vectura Limited, and that the patent was not invalid. The district court...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases